• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国患有浸润性宫颈癌的女性:特征和预防的潜在障碍。

U.S. Women with Invasive Cervical Cancer: Characteristics and Potential Barriers to Prevention.

机构信息

Epidemic Intelligence Service, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

出版信息

J Womens Health (Larchmt). 2024 May;33(5):594-603. doi: 10.1089/jwh.2023.0462. Epub 2024 Apr 12.

DOI:10.1089/jwh.2023.0462
PMID:38608239
Abstract

Although invasive cervical cancer (ICC) rates have declined since the advent of screening, the annual age-adjusted ICC rate in the United States remains 7.5 per 100,000 women. Failure of recommended screening and management often precedes ICC diagnoses. The study aimed to evaluate characteristics of women with incident ICC, including potential barriers to accessing preventive care. We abstracted medical records for patients with ICC identified during 2008-2020 in five U.S. population-based surveillance sites covering 1.5 million women. We identified evidence of adverse social and medical conditions, including uninsured/underinsured, language barrier, substance use disorder, incarceration, serious mental illness, severe obesity, or pregnancy at diagnosis. We calculated descriptive frequencies and compared potential barriers by race/ethnicity, and among women with and without symptoms at diagnosis using chi-square tests. Among 1,606 women with ICC (median age: 49 years; non-White: 47.4%; stage I: 54.7%), the majority (68.8%) presented with symptoms. Forty-six percent of women had at least one identified potential barrier; 15% had multiple barriers. The most common potential barriers among all women were being underinsured/uninsured (17.3%), and language (17.1%). Presence of any potential barrier was more frequent among non-White women and women with than without symptoms ( < 0.05). In this population-based descriptive study of women with ICC, we identified adverse circumstances that might have prevented women from seeking screening and treatment to prevent cancer. Interventions to increase appropriate cervical cancer screening and management are critical for reducing cervical cancer rates.

摘要

虽然自筛查出现以来,侵袭性宫颈癌 (ICC) 的发病率有所下降,但美国每年每 10 万名妇女中 ICC 的年龄调整发病率仍为 7.5 例。推荐的筛查和管理的失败往往先于 ICC 诊断。本研究旨在评估患有 ICC 的女性的特征,包括获得预防保健的潜在障碍。 我们从五个美国基于人群的监测站点的病历中提取了 2008 年至 2020 年间诊断为 ICC 的患者的记录,这些站点覆盖了 150 万女性。我们确定了不良社会和医疗条件的证据,包括没有保险/保险不足、语言障碍、药物使用障碍、监禁、严重精神疾病、严重肥胖或诊断时怀孕。我们计算了描述性频率,并使用卡方检验比较了不同种族/族裔的潜在障碍,以及在诊断时有症状和无症状的女性之间的潜在障碍。 在 1606 名患有 ICC 的女性中(中位年龄:49 岁;非白人:47.4%;I 期:54.7%),大多数(68.8%)有症状。46%的女性有至少一个确定的潜在障碍;15%的女性有多个障碍。所有女性中最常见的潜在障碍是保险不足/没有保险(17.3%)和语言障碍(17.1%)。在非白人女性和有症状的女性中,存在任何潜在障碍的情况更为常见(<0.05)。 在这项基于人群的 ICC 女性描述性研究中,我们确定了可能导致女性无法寻求筛查和治疗以预防癌症的不良情况。增加适当的宫颈癌筛查和管理的干预措施对于降低宫颈癌发病率至关重要。

相似文献

1
U.S. Women with Invasive Cervical Cancer: Characteristics and Potential Barriers to Prevention.美国患有浸润性宫颈癌的女性:特征和预防的潜在障碍。
J Womens Health (Larchmt). 2024 May;33(5):594-603. doi: 10.1089/jwh.2023.0462. Epub 2024 Apr 12.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997-2012.美国医疗服务不足女性的宫颈癌筛查:1997 - 2012年国家乳腺癌和宫颈癌早期检测项目的结果
Cancer Causes Control. 2015 May;26(5):671-86. doi: 10.1007/s10552-015-0524-5. Epub 2015 Mar 18.
4
Eligibility for and reach of the National Breast and Cervical Cancer Early Detection Program, 2018-2021.2018 - 2021年国家乳腺癌和宫颈癌早期检测项目的资格条件及覆盖范围
Cancer Causes Control. 2025 May;36(5):531-538. doi: 10.1007/s10552-024-01947-4. Epub 2025 Jan 8.
5
Disparities in vaccinations and cancer screening among U.S.- and foreign-born Arab and European American non-Hispanic White women.美国出生和外国出生的阿拉伯裔及非西班牙裔白人欧美女性在疫苗接种和癌症筛查方面的差异。
Womens Health Issues. 2015 Jan-Feb;25(1):56-62. doi: 10.1016/j.whi.2014.10.002. Epub 2014 Dec 12.
6
Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.在里约热内卢尼泰罗伊市参加家庭医疗项目的妇女中,宫颈癌筛查的障碍。
Arch Gynecol Obstet. 2013 Jan;287(1):53-8. doi: 10.1007/s00404-012-2511-3. Epub 2012 Aug 12.
7
Assessment of US Preventive Services Task Force Guideline-Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019.评估 2005 年至 2019 年期间,按年龄、种族和民族、性取向、农村和保险状况划分的美国预防服务工作组指南一致的宫颈癌筛查率和筛查不足的原因。
JAMA Netw Open. 2022 Jan 4;5(1):e2143582. doi: 10.1001/jamanetworkopen.2021.43582.
8
Cervical Screening and Colposcopy Management of Women Age 24 and Under.24 岁及以下女性的宫颈筛查和阴道镜检查管理。
J Obstet Gynaecol Can. 2020 Dec;42(12):1518-1524. doi: 10.1016/j.jogc.2020.06.013. Epub 2020 Jul 1.
9
Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.满足服务不足妇女的宫颈癌筛查需求:2004-2006 年全国乳腺癌和宫颈癌早期检测计划。
Cancer Causes Control. 2010 Jul;21(7):1081-90. doi: 10.1007/s10552-010-9536-3. Epub 2010 Apr 2.
10
Improving Equitable Access to Cervical Cancer Screening and Management.提高宫颈癌筛查和管理的公平性。
Am J Nurs. 2020 Nov;120(11):58-67. doi: 10.1097/01.NAJ.0000721944.67166.17.

引用本文的文献

1
Prognostic evaluation and treatment strategies for cervical cancer in pregnancy: a systematic review and meta-analysis.妊娠期宫颈癌的预后评估与治疗策略:一项系统评价与荟萃分析
BMC Cancer. 2025 Mar 18;25(1):502. doi: 10.1186/s12885-025-13827-4.
2
A Proposed mHealth Intervention to Address Patient Barriers to Colposcopy Attendance: Qualitative Interview Study of Clinic Staff and Patient Perspectives.一项旨在解决患者阴道镜检查就诊障碍的移动健康干预措施:针对诊所工作人员和患者观点的定性访谈研究
JMIR Form Res. 2025 Jan 14;9:e55043. doi: 10.2196/55043.

本文引用的文献

1
Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype.按组织学亚型划分的宫颈癌发病率、生存率和死亡率的种族和民族差异。
J Clin Oncol. 2023 Feb 10;41(5):1059-1068. doi: 10.1200/JCO.22.01424. Epub 2022 Dec 1.
2
Effect of Patient Characteristics on Uptake of Screening Using a Mailed Human Papillomavirus Self-sampling Kit: A Secondary Analysis of a Randomized Clinical Trial.患者特征对邮寄人乳头瘤病毒自我采样试剂盒筛查参与度的影响:一项随机临床试验的二次分析。
JAMA Netw Open. 2022 Nov 1;5(11):e2244343. doi: 10.1001/jamanetworkopen.2022.44343.
3
Increasing breast, cervical, and colorectal cancer screening among rural women: Baseline characteristics of a randomized control trial.
提高农村妇女的乳腺癌、宫颈癌和结直肠癌筛查率:一项随机对照试验的基线特征。
Contemp Clin Trials. 2022 Dec;123:106986. doi: 10.1016/j.cct.2022.106986. Epub 2022 Oct 31.
4
National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2021.美国2021年13至17岁青少年的国家疫苗接种覆盖率——国家免疫调查-青少年
MMWR Morb Mortal Wkly Rep. 2022 Sep 2;71(35):1101-1108. doi: 10.15585/mmwr.mm7135a1.
5
Improving cervical cancer screening rates: a scoping review of resources and interventions.提高宫颈癌筛查率:资源和干预措施的范围综述。
Cancer Causes Control. 2022 Nov;33(11):1325-1333. doi: 10.1007/s10552-022-01618-2. Epub 2022 Aug 18.
6
HPV type-specific trends in cervical precancers in the United States, 2008 to 2016.美国 2008 至 2016 年宫颈前病变中 HPV 型别特异性趋势。
Int J Cancer. 2023 Jan 15;152(2):137-150. doi: 10.1002/ijc.34231. Epub 2022 Sep 26.
7
Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018.人乳头瘤病毒疫苗在美国引入后 12 年的影响和效果,2003 至 2018 年。
Ann Intern Med. 2022 Jul;175(7):918-926. doi: 10.7326/M21-3798. Epub 2022 May 17.
8
Prevalence and determinants of late-stage presentation among cervical cancer patients, a systematic review and meta-analysis.宫颈癌患者晚期就诊的流行率及决定因素:系统评价和荟萃分析。
PLoS One. 2022 Apr 27;17(4):e0267571. doi: 10.1371/journal.pone.0267571. eCollection 2022.
9
Impact of prior underinsurance on cervical cancer screening among Davidson County, Tennessee, women diagnosed with invasive cervical cancer, 2008-2018.田纳西州戴维森县 2008 年至 2018 年间被诊断患有浸润性宫颈癌的妇女中,既往保险不足对宫颈癌筛查的影响。
BMC Womens Health. 2022 Mar 12;22(1):68. doi: 10.1186/s12905-022-01638-9.
10
Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management.HPV 型别相关的种族和民族的宫颈癌前病变和癌症:对疫苗接种、筛查和管理的影响。
J Natl Cancer Inst. 2022 Jun 13;114(6):845-853. doi: 10.1093/jnci/djac034.